المؤلفون: Hindi, N., Razak, A., Rosembaum, E., Jonczak, E., Hamacher, R., Rutkowski, P., Bhadri, V. A., Skryd, A., Brahmi, M., Alshibany, A., Jagodzinska-Mucha, P., Bauer, S., Connolly, Emma, Gelderblom, H., Boye, K., Henon, C., Bae, S., Bogefors, K., Vincenzi, B., Martinez-Trufero, J., Lopez-Martin, J. A., Redondo, A., Valverde, C., Blay, J. Y., Moura, D. S., Gutierrez, A., Tap, W., Martin-Broto, Javier

المصدر: ESMO Open. 8(6)

مصطلحات موضوعية: alveolar soft-part sarcoma, immune checkpoint, immunotherapy, progression-free survival, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology

الوصول الحر: https://lup.lub.lu.se/record/1ede7563-37b1-4de7-adae-2096dcfb68baTest
http://dx.doi.org/10.1016/j.esmoop.2023.102045Test

المؤلفون: Razak, Albiruni Abdul, Rosenbaum, E., Jonczak, Emily, Hamacher, Rainer, Rutkowski, Piotr, Valverde Morales, Claudia Maria, HINDI, NADIA

المساهمون: Institut Català de la Salut, Hindi N Medical Oncology Department, Fundacion Jimenez Diaz University Hospital and Hospital General de Villalba, Madrid. Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain. Razak A Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada. Rosenbaum E Memorial Sloan Kettering Cancer Center, New York. Jonczak E Department of Hematology Oncology, Miami University, Miami, USA. Hamacher R Medical Oncology Department, West German Cancer Center, University Hospital Essen, Essen, Germany. Rutkowsk P Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Tumors de parts toves - Tractament, Immunoteràpia, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Muscle Tissue::Sarcoma, Alveolar Soft Part, Other subheadings::Other subheadings::Other subheadings::/drug therapy, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido muscular::sarcoma alveolar de partes blandas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

وصف الملف: application/pdf

العلاقة: ESMO Open;8(6); https://doi.org/10.1016/j.esmoop.2023.102045Test; Hindi N, Razak A, Rosembaum E, Jonczak E, Hamacher R, Rutkowski P, et al. Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry. ESMO Open. 2023 Dec;8(6):102045.; https://hdl.handle.net/11351/10835Test; 001130490900001

الإتاحة: https://doi.org/10.1016/j.esmoop.2023.102045Test
https://hdl.handle.net/11351/10835Test